| 1 | [SID26657808] | Active | AC50 | 0.641 | MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity [AID588345, Type: confirmatory] | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | AC50 | 0.641 [uM] | | BioAssay | MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity | | AID | 588345 | | BioAssay type | confirmatory | | Target | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] | | PubMed | | | Data Table |  |
|
| 2 | [SID26657808] | Active | AC50 | 0.641 | MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity [AID588345, Type: confirmatory] | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | AC50 | 0.641 [uM] | | BioAssay | MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity | | AID | 588345 | | BioAssay type | confirmatory | | Target | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] | | PubMed | | | Data Table |  |
|
| 3 | [SID26657808] | Active | Potency | 3.1623 | qHTS Assay for NPC1 Promoter Activators [AID485313, Type: confirmatory] | NPC1 gene product [Homo sapiens] [gi:255652944] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for NPC1 Promoter Activators | | AID | 485313 | | BioAssay type | confirmatory | | Target | NPC1 gene product [Homo sapiens] [gi:255652944] | | PubMed | | | Data Table |  |
|
| 4 | [SID26657808] | Active | Potency | 3.9811 | qHTS Assay for Rab9 Promoter Activators [AID485297, Type: confirmatory] | RAB9A gene product [Homo sapiens] [gi:4759012] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for Rab9 Promoter Activators | | AID | 485297 | | BioAssay type | confirmatory | | Target | RAB9A gene product [Homo sapiens] [gi:4759012] | | PubMed | | | Data Table |  |
|
| 5 | [SID26657808] | Active | Potency | 5.2119 | qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21 [AID2289, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | Potency | 5.2119 [uM] | | BioAssay | qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21 | | AID | 2289 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID26657808] | Active | Potency | 6.3096 | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 7 | [SID26657808] | Active | Potency | 6.3096 | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 8 | [SID26657808] | Active | Potency | 8.4921 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | Potency | 8.4921 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 9 | [SID26657808] | Active | EC50 | 12.4 | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | EC50 | 12.4 [uM] | | BioAssay | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity | | AID | 434954 | | BioAssay type | confirmatory | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 10 | [SID26657808] | Active | EC50 | 12.4 | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | EC50 | 12.4 [uM] | | BioAssay | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity | | AID | 434954 | | BioAssay type | confirmatory | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 11 | [SID26657808] | Active | EC50 | 12.4 | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity [AID434954, Type: confirmatory] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | EC50 | 12.4 [uM] | | BioAssay | Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta Activity | | AID | 434954 | | BioAssay type | confirmatory | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 12 | [SID26657808] | Active | Potency | 23.0999 | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504466, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | Potency | 23.0999 [uM] | | BioAssay | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504466 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 13 | [SID26657808] | Active | IC50 | 26.05 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens [AID624330, Type: confirmatory] | RACGAP1 gene product [Homo sapiens] [gi:21361397] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | IC50 | 26.05 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens | | AID | 624330 | | BioAssay type | confirmatory | | Target | RACGAP1 gene product [Homo sapiens] [gi:21361397] | | PubMed | | | Data Table |  |
|
| 14 | [SID26657808] | Active | Potency | 28.1838 | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 15 | [SID26657808] | Active | IC50 | 33.86 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Counter Screen Coupled Enzyme [AID624351, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | IC50 | 33.86 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Counter Screen Coupled Enzyme | | AID | 624351 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID103599609] | Active | IC50 | 34.6 | Growth inhibition of mouse Hepa-1c1c7 cells [AID355762, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103599609 | | CID | 16376440 | | Outcome | Active | | IC50 | 34.6 [uM] | | BioAssay | Growth inhibition of mouse Hepa-1c1c7 cells | | AID | 355762 | | BioAssay type | Literature | | Target | | | PubMed | 12762787 | | Data Table |  |
|
| 17 | [SID26657808] | Active | Potency | 79.4328 | Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) - Round 2 Cherry Picks [AID504841, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) - Round 2 Cherry Picks | | AID | 504841 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 18 | [SID26657808] | Active | | | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652010, Type: screening] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652010 | | BioAssay type | screening | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 19 | [SID26657808] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1) [AID504766, Type: screening] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1) | | AID | 504766 | | BioAssay type | screening | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 20 | [SID26657808] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID26657808] | Active | | | Counterscreen for activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM): Luminescence-based cell-based high throughput screening assay to identify non-selective compounds using the VP16 reporter assay [AID686939, Type: screening] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Counterscreen for activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM): Luminescence-based cell-based high throughput screening assay to identify non-selective compounds using the VP16 reporter assay | | AID | 686939 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID26657808] | Active | | | Counterscreen for activators of kallikrein-7 (K7) zymogen: Fluorescence intensity-based biochemical high throughput counterscreen assay for activators that optically interfere with measurement of EDANS-DABCYL fluorescence [AID686952, Type: screening] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Counterscreen for activators of kallikrein-7 (K7) zymogen: Fluorescence intensity-based biochemical high throughput counterscreen assay for activators that optically interfere with measurement of EDANS-DABCYL fluorescence | | AID | 686952 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID26657808] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 24 | [SID26657808] | Active | | | A qHTS for Small Molecule Inhibitors of Shiga Toxin [AID2315, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | A qHTS for Small Molecule Inhibitors of Shiga Toxin | | AID | 2315 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 25 | [SID26657808] | Active | | | Counterscreen for activators of the GAA850 frataxin promoter: luminescence-based cell-based high throughput screening assay to identify activators of the GAA30 frataxin promoter [AID588350, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Counterscreen for activators of the GAA850 frataxin promoter: luminescence-based cell-based high throughput screening assay to identify activators of the GAA30 frataxin promoter | | AID | 588350 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID26657808] | Active | | | Luminescence-based cell-based high throughput confirmation assay for activators of the GAA850 frataxin (FXN) promoter [AID588351, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for activators of the GAA850 frataxin (FXN) promoter | | AID | 588351 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID85843928] | Active | | | Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity [AID2322, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 85843928 | | CID | 16376440 | | Outcome | Active | | BioAssay | Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity | | AID | 2322 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID26657808] | Active | | | HTS to identify inhibitors of zVAD Induced Cell Death in L929 Cells. [AID1377, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | HTS to identify inhibitors of zVAD Induced Cell Death in L929 Cells. | | AID | 1377 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID26657808] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID26657808] | Active | IC50 | | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. [AID1434, Type: confirmatory] | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. | | AID | 1434 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] | | PubMed | | | Data Table |  |
|
| 31 | [SID26657808] | Active | IC50 | | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. [AID1434, Type: confirmatory] | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. | | AID | 1434 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] | | PubMed | | | Data Table |  |
|
| 32 | [SID26657808] | Active | | | uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase [AID2544, Type: screening] | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase | | AID | 2544 | | BioAssay type | screening | | Target | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] | | PubMed | | | Data Table |  |
|
| 33 | [SID26657808] | Active | | | uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase [AID2544, Type: screening] | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase | | AID | 2544 | | BioAssay type | screening | | Target | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] | | PubMed | | | Data Table |  |
|
| 34 | [SID26657808] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 35 | [SID26657808] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 36 | [SID26657808] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 37 | [SID26657808] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 38 | [SID26657808] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 39 | [SID26657808] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 40 | [SID26657808] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput screening assay to identify agonists of the vasopressin 1 receptor (V1R), in triplicate [AID434991, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput screening assay to identify agonists of the vasopressin 1 receptor (V1R), in triplicate | | AID | 434991 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 41 | [SID26657808] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput screening assay to identify agonists of the vasopressin 1 receptor (V1R), in triplicate [AID434991, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput screening assay to identify agonists of the vasopressin 1 receptor (V1R), in triplicate | | AID | 434991 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 42 | [SID26657808] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput screening assay to identify agonists of the vasopressin 1 receptor (V1R), in triplicate [AID434991, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput screening assay to identify agonists of the vasopressin 1 receptor (V1R), in triplicate | | AID | 434991 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 43 | [SID26657808] | Active | | | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS [AID485317, Type: screening] | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS | | AID | 485317 | | BioAssay type | screening | | Target | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] | | PubMed | | | Data Table |  |
|
| 44 | [SID26657808] | Active | | | Fluorescence polarization-based cell-based high throughput confirmation assay for inhibitors of insulin-degrading enzyme (IDE) [AID435028, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based high throughput confirmation assay for inhibitors of insulin-degrading enzyme (IDE) | | AID | 435028 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 45 | [SID26657808] | Active | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) [AID434962, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) | | AID | 434962 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 46 | [SID26657808] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 47 | [SID26657808] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 48 | [SID26657808] | Active | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 49 | [SID26657808] | Active | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 50 | [SID26657808] | Active | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26657808 | | CID | 16376440 | | Outcome | Active | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|